1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Dexpramipexole: new trials by email Literature Review of Dexpramipexole trials Research Report on Dexpramipexole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Extension Study of Dexpramipexole in ALS Dexpramipexole - Amyotrophic Lateral Sclerosis | Phase 3 | Terminated | Knopp Biosciences | 616 | 2012-06-01 | 2022-05-03 |
| Phase 3 Study of Dexpramipexole in ALS Dexpramipexole, Placebo - Amyotrophic Lateral Sclerosis | Phase 3 | Completed | Knopp Biosciences | 942 | 2011-03-01 | 2021-06-07 |
Amyotrophic Lateral Sclerosis (2) · Motor Neuron Disease (2)
Australia (2) · Belgium (2) · Canada (2) · France (2) · Germany (2) · Ireland (2) · Netherlands (2) · Spain (2) · Sweden (2) · United Kingdom (2) · United States (2)
Merit Cudkowicz, MD, MSc (1) · Michael Bozik, MD (1)